Corteva, INC

Market Movers (8-K)

See all →
NYSE
Corteva and EIDP, Inc. are subject to a temporary restraining order following litigation challenging their separation into two independent companies.
NYSE
Corteva, Inc. has completed its separation into two independent companies, spinning off its seed operating segment into Vylor Inc., and has appointed new directors and officers.
NYSE
Corteva, Inc.'s subsidiary, EIDP, Inc., has successfully completed an exchange offer and consent solicitation for its outstanding senior notes, resulting in a reduction of its total outstanding debt.
NYSE
Corteva, Inc. and Vylor Inc. have executed an Intellectual Property Matters Agreement, detailing the licensing and ownership of intellectual property following their separation.
NYSE
New Corteva's unaudited pro forma combined financial statements detail its projected financial position and results of operations as a standalone entity following its separation from Corteva, Inc.
NYSE
Corteva, Inc. has successfully completed the separation of its seed operating segment into a new independent, publicly traded company named Vylor Inc.

Quarterly Earnings (10-Q)

See all →
NYSE
Corteva, Inc. announced its second quarter 2026 financial results, showing a slight decrease in net sales but an increase in operating EBITDA, while managing ongoing restructuring and legal matters.
NYSE
Corteva reported strong Q1 2026 growth with net sales up 11% to $4.9 billion while advancing its planned business separation.
NYSE
Corteva reports strong third-quarter and year-to-date 2025 financial results, driven by volume growth and cost efficiencies, alongside a plan to separate its Seed and Crop Protection businesses.
Capital raise
Better than expected
NYSE
Corteva, Inc. reported a significant increase in net income and earnings per share for the second quarter and first half of 2025, driven by strong volume growth, strategic pricing, and cost efficiencies.
Capital raise
Better than expected
NYSE
Corteva's Q1 2025 earnings surged despite a slight sales decrease, fueled by strategic pricing in the Seed segment and effective cost management initiatives.
Better than expected
NYSE
Corteva's third-quarter results show a net loss, impacted by pricing pressures and restructuring charges, despite some volume growth in Crop Protection.
Worse than expected

Annual Reports (10-K)

NYSE
Corteva, Inc. reported significant financial improvements in 2025, including a 3% net sales increase and a 14% rise in operating EBITDA, while announcing plans to separate its Seed and Crop Protection businesses into two independent public companies by late 2026.
Better than expected
Capital raise
NYSE
Corteva's 2024 results show a slight dip in net sales due to pricing pressures in crop protection, offset by volume increases in seed and cost-saving measures.
Worse than expected
NYSE
Corteva, Inc. and its subsidiary EIDP, Inc. have released their combined 2023 annual results, showing a slight decrease in net sales but an increase in operating EBITDA.
Worse than expected

Insider Trading (Form 4)

See all →
NYSE
Brian Titus, See Remarks of Corteva, Inc., reported multiple transactions in common stock on October 1, 2026.
NYSE
Luther C Kissam Iv, Chief Executive Officer of Corteva, Inc., reported a transaction in 127,949 shares of common stock on October 1, 2026.
NYSE
Jennifer Amy Johnson, SVP, Chief Legal Officer of Corteva, Inc., reported a transaction in 446 shares of common stock on September 15, 2026.
NYSE
David Paul Johnson, EVP, Chief Financial Officer of Corteva, Inc., reported a transaction in 8,517 shares of common stock on September 16, 2026.
NYSE
Christopher J. Policinski, a Director of Corteva, Inc., received 413 shares of common stock on July 31, 2026.
NYSE
Nayaki R Nayyar, a Director of Corteva, Inc., received 413 shares of common stock on July 31, 2026.

Proxy Statements (Def-14A)

NYSE
Corteva, Inc. announces solid 2025 financial results, significant shareholder returns, and proposes a refreshed board slate for its upcoming April 28, 2026 Annual Stockholder Meeting.
Better than expected
NYSE
Corteva, Inc. is soliciting stockholder votes on the election of directors, approval of executive compensation, and ratification of PricewaterhouseCoopers LLP as its independent auditor for 2025.
NYSE
Corteva's 2025 proxy statement outlines key agenda items for the annual stockholder meeting, including the election of directors, an advisory vote on executive compensation, and the ratification of the company's independent auditor.
NYSE
Corteva Inc. announces its 2024 Annual Meeting of Stockholders, urging investors to vote on key proposals including the election of directors, executive compensation, and ratification of the company's accounting firm.
NYSE
Corteva, Inc. releases its proxy statement outlining the agenda for the 2024 Annual Stockholder Meeting, including director elections, executive compensation approval, and a certificate of incorporation amendment.

Schedule 13G - Passive Investments

See all →
NYSE
Capital World Investors has disclosed a beneficial ownership of 6.6% in Corteva, Inc., holding 43,841,218 shares.
NYSE
Capital World Investors has reported beneficial ownership of 36,863,390 shares, representing 5.5% of Corteva, Inc.'s common stock as of March 31, 2026.
NYSE
FMR LLC and Abigail P. Johnson have reported beneficial ownership of 5.2% of Corteva Inc.'s common stock as of March 31, 2026.
NYSE
Vanguard Capital Management has reported a beneficial ownership of 7.56% in Corteva Inc. common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Corteva Inc. following an internal realignment that disaggregated reporting.
NYSE
State Street Corporation has disclosed a 5.2% beneficial ownership in Corteva Inc., holding significant shared voting and dispositive power.